“Neurostimulation Devices Market Research Report- Global Forecast To 2022” report by Market Research Future provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
Global Neurostimulation Devices Market – Highlights
Neurostimulation is a modulation of the nervous system’s activity. It is deliberately carried out by using invasive and non-invasive techniques. Implantable stimulation devices are most commonly used in the treatment of the neurological conditions such as epilepsy, Parkinson’s disease, dystonia, tremors, depression, obsessive compulsive disorder, diabetic neuropathy, and few other conditions. Increasing cases of the neurological disorders such as chronic pain and depression high adoption of the neurostimulation therapy are likely to improve the market of neurostimulation devices.
Get Free Sample @ https://www.marketresearchfuture.com/sample_request/2263
The Global Neurostimulation Devices Market is growing at a rapid scale due to the increase in the number of neurological diseases. This increase in prevalence is a result of shifting lifestyle and awareness amongst patients concerning neurological diseases, relevant surgeries, and therapies. The market is also driven by factors such as steadily increasing medical expenditure, increasing obese population, strong rate of encouragement from the government, and continuous increasing demand for neurostimulation devices.
Global Neurostimulation Devices Market – Key Players
Some of the key players in this market are:
- Autonomic Technologies
- Boston Scientific
- ElectroCore
- ImThera Medical
- Inspire Medical Systems
- LivaNova (Cyberonics)
- Medtronic
- NeuroMetrix
- NeuroPace
- Neuros Medical
- NeuroSigma
- Nevro Corporation
- SPR Therapeutics
- Jude Medical
- Synapse Biomedical
March 21st, 2019
It was announced that the world’s first ever wireless miniature implantable long-term therapy to be now available in Canada. The pain-relief neurostimulator has been changing the lives of many and is expected to continue its proliferation in the Canada region as well.
Global Neurostimulation Devices Market – Segments
The Global Neurostimulation Devices Market segmentation is done on the basis of application, type, and end-user.
By application, the market includes Parkinson’s disease, epilepsy, dystonia, urinary and fecal incontinence, depression, tremors, gastroparesis, pain management, and others.
By end-user, the market divides into external devices and implantable devices. External devices segment breaks down transcranial magnetic stimulator and transcutaneous electrical nerve stimulator. Implantable devices segment comprises of spinal cord simulators, sacral nerve stimulators, cochlear implants, vagus nerve stimulators, and deep brain stimulators gastric electric stimulators.
By end-user, the market includes research institutes, hospitals & clinics, cognitive care centers, and others.
Global Neurostimulation Devices Market – Regional Analysis
America account for the largest market share in neurostimulation devices market. The growth is attributed to an increasing demand for cardiovascular devices for the treatment of cardiovascular diseases and increasing prevalence of neurological diseases in the market. Additionally, the market growth is also boosted by increasing expenditure on neurostimulation devices in North America.
Additionally, invention of new technology, increasing awareness, and investments in research and development have boosted the neurostimulation market. However, high cost associated with monitoring and diagnosis of disease may restrain the market growth.
Additionally, rising geriatric population across the globe also fuels the growth of the Neurostimulation Devices Market. According to World Population Ageing Report, in 2017, there are an estimated 962 million people aged 60 or over globally, which is 13% of the total global population. According to the population reference bureau, the number of Americans ageing 65 and older is projected to more than double from 46 million in 2015 to over 98 million by 2060. According to the StastsCan, 2015, over 5.7 million Canadians have aged 65 and older, which was 16.1 % of Canadian population.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com